- Barracloughs News
Demodex Mites and How to Fight Them
It's not a nice thought, but Demodex is the most common microscopic mite found in the human skin. These mites can be found on your eyelids and Demodex prevalence increases with age. It is observed in 84% of the population at age 60 and an incredible 100% of the population over the age of 70.
Demodex is considered to play a role in the progress of ocular surface diseases such as chronic blepharitis, MGD, dry eye and affects contact lens wearers. Obviously these mites are tiny but they can cause a number of irritations:
- Itching of the lid margin
- Foreign body sensation
- Burning of the eyes and/or lids
- Dryness and lid margin inflammation
- Fluctuating blurry vision
Cylindrical dandruff at the base of the eyelashes is regarded as a key sign of Demodex infestation, particularly when conventional treatments for blepharitis fail. A common treatment is tea tree oil which is a natural essential oil steam distilled from the Australian native plant Melaleuca alternifolia, this is toxic to Demodex. However, pure tea tree oil can be toxic so it is essential to extract only the effective parts for safe use in treatment. Terpinen-4-ol is the best choice and it is the most active ingredient of tea tree oil.
Demodex prevalence increases with age and is observed in
- 84% of the population at age 60
- 100% of the population over 70
We recommend the use of Blephademodex® which is clinically proven to improve symptoms linked to Demodex Blepharitis, such as eyelid itching, burning and dryness. Redness at the edges of the eyelids is also reduced. The innovative formulation of these sterile wipes contains a purified version of Terinen-4-ol, meaning crusts, dandruffs, impurities and infectious agents on eyelids and eyelashes are cleaned away. Another ingredient is sodium hyaluronate, a natural skin moisturising agent, leaving sensitive skin soothed and regenerated.
Blephademodex is available at all Barracloughs stores, along with a wide range of dry eye and blepharitis products.
Liu J, et al. Curr Opin Allergy Clin Immunol 2010; 10 (5): 505-510.
Norn MS. Dan Med Bull 1971; 18 (1): 14-17.
Koo H, et al. J Korean Med Sci 2012; 27: 1574-1579.
Zhao YE, et al. Ophthalmic Epidemiol 2012; 19 (2): 95-102.
Kabatas N, et al. Eye Contact Lens 2017; 43 (1): 64-67.
Markoulli M, et al. Clin Optom 2017; 9: 41-48.
Gao YY, et al. Investigative Ophthalmology & Visual Science 2005; 46 (9): 3089-3094.
Tighe S, et al. Transl Vis Sci Technol 2013; 2 (7): 2.
Gao YY, et al. Br J Ophthalmol. 2005;89(11): 1468e73.